About Auronext Pharma Private Limited
Data last updated: 26 July 2025
Auronext Pharma Private Limited was a private limited company based in Hyderabad, Telangana, India, operated as a subsidiary of Aurobindo Pharma Ltd. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It specialised in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 02 July 2009.
Registered with ROC Hyderabad under CIN U74999TG2009PTC109591.
Capital: an authorised share capital of ₹255 Cr and a paid-up capital of ₹124.98 Cr. It was led by directors including Madan Mohan Reddy Mettu and Sapna.
Last AGM: 19 June 2023. Financial statements filed for year ended 31 March 2023. Office: Galaxy Floors 22 – 24 Plot No. 1 Survey No. 83/1 Hyderabad Knowledge City Raidurg Panmak, Tha, Telangana, India – 500032.
As per the financials filed for FY 2023, the company reported a revenue of ₹75.75 Lakh, a growth of 23% compared to the previous year.
The company had a reported workforce of approximately 293 employees prior to being dissolved. It operated as a subsidiary of Aurobindo Pharma Ltd.
The company was associated with 2 brands - Auronext Pharma, Aurobindo Pharma. As per MCA filings, the company had satisfied charges of ₹36.5 Cr on record.
The company has been merged (amalgamated) with another entity and no longer exists separately. Business activities, if any, continue under the successor entity. The last known website on record is aurobindo.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered AddressGalaxy Floors 22 – 24 Plot No. 1 Survey No. 83/1 Hyderabad Knowledge City Raidurg Panmak, Tha, Telangana, India – 500032
-
IndustryPharma, Drug Formulation & Development, API Manufacturers
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Auronext Pharma Private Limited
Auronext Pharma Private Limited has one previous CIN (Corporate Identification Number): U74999DL2009PTC191842. The current CIN is U74999TG2009PTC109591, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74999TG2009PTC109591 | Current |
| U74999DL2009PTC191842 | Previous |
Associated Brands with Auronext Pharma Private Limited
Auronext Pharma Private Limited operates two associated brands: Auronext Pharma and Aurobindo Pharma. These brands represent Auronext Pharma Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Generic biocatalytic solutions are provided for pharmaceutical applications. | aurobindo.com | |
| Offers comprehensive outsourced API production services for the pharmaceutical industry. | auronext.com |
Competitors & Alternatives of Auronext Pharma Private Limited
Brands and companies operating in the same space as Auronext Pharma Private Limited include Laurus Labs, Concord Biotech, Symbiotec and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Laurus Labs
|
Pharmaceutical and biotechnology company | Hyderabad, India, India | 2005 |
Concord Biotech
|
APIs and enzymes are manufactured through fermentation by the CDMO. | Ahmedabad, India, India | 2000 |
Symbiotec
|
Non-sterile steroid hormone-based APIs and intermediates are manufactured. | Indore, India, India | 2002 |
BDR Pharmaceuticals Internationals
|
APIs and finished products are developed and manufactured. | Mumbai, India, India | 2003 |
Almac Group
|
Integrated CDMO services for biopharma R&D and manufacturing are offered. | Craigavon, United Kingdom, United Kingdom | 2001 |
Beijing Biostar Technologies
|
APIs, intermediates, and biochemical reagents are developed and manufactured. | Beijing, China, China | 2002 |
Indoco Remedies
|
APIs manufacturing and formulation services are provided in therapeutic segments. | Mumbai, India, India | 1947 |
Pharmaceutics International
|
Pharmaceutical dosage forms are manufactured by this CDMO. | Hunt Valley, United States, United States | 1994 |
Sterling Pharma Solutions
|
Contract development, manufacturing, and analytical services for APIs are offered. | Dudley, United Kingdom, United Kingdom | 2016 |
Provepharm Life Solutions
|
APIs and drug products are developed and valorized in pharmaceuticals. | Marseille, France, France | 1998 |
Business Activity of Auronext Pharma Private Limited
Auronext Pharma Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Auronext Pharma Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Auronext Pharma Private Limited
Auronext Pharma Private Limited is audited by G P M & Associates for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| G P M & Associates | Locked | Locked | Locked |
Complete auditor history for Auronext Pharma Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors and KMP of Auronext Pharma Private Limited
Auronext Pharma Private Limited currently reports 4 directors and 1 key managerial person. 13 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Madan Mohan Reddy Mettu
Also directs:
Mss Packaging Industries Llp, Aurobindo Pharma Ltd, Engenra Biologics Private Limited and 5 more
|
Director | 31 Aug 2020 | 5 Years 11 Months | As last reported |
|
Sapna
Also directs:
Aurigene Pharmaceutical Services Limited
|
Director | 23 May 2019 | 7 Years 3 Months | As last reported |
| Jacob Joseph | Whole-Time Director | 01 Jul 2021 | 5 Years 1 Months | As last reported |
| Venkata Radhakrishna Racharla | Company Secretary | 15 Apr 2019 | 7 Years 4 Months | As last reported |
|
Sarath Chandra Reddy Penaka
Also directs:
Aurobindo Pharma Ltd, Sarath Penaka Enterprises Llp, Naqsh Global Ventures Llp and 5 more
|
Director | 20 Aug 2009 | 17 Years 0 Months | As last reported |
Financials of Auronext Pharma Private Limited FY 2023 filings available
Auronext Pharma Private Limited reported revenue of ₹75.75 Lakh (up 23.00% YoY) for FY 2023.
Ten-year financial statements for Auronext Pharma Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Auronext Pharma Private Limited
Shareholding and ownership data for Auronext Pharma Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Auronext Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Jul 2016 | Yes Bank Limited | ₹35 Cr | Satisfied |
| 02 Feb 2010 | Axis Bank Limited | ₹1.5 Cr | Satisfied |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Auronext Pharma Private Limited
Auronext Pharma Private Limited has a workforce of 293 employees as of Apr 05, 2024.
Employee and EPFO history for Auronext Pharma Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Auronext Pharma Private Limited
GST registrations and filing compliance for Auronext Pharma Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Auronext Pharma Private Limited
Credit ratings, litigation, and regulatory alerts for Auronext Pharma Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Auronext Pharma Private Limited
MSME payment history for Auronext Pharma Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Auronext Pharma Private Limited
Corporate group structure for Auronext Pharma Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Auronext Pharma Private Limited
MCA filings and documents for Auronext Pharma Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Auronext Pharma Private Limited
Recent News on Auronext Pharma Private Limited
Frequently Asked Questions about Auronext Pharma Private Limited
Auronext Pharma Private Limited has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Auronext Pharma Private Limited is a amalgamated private limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 02 July 2009 and is registered under CIN U74999TG2009PTC109591. The company was amalgamated as per MCA records and no longer exists as a legal entity.
Auronext Pharma Private Limited was incorporated on 02 July 2009. Registered with ROC Hyderabad.
The current directors and KMP of Auronext Pharma Private Limited are:
- Madan Mohan Reddy Mettu - Director
- Sapna - Director
- Jacob Joseph - Whole-Time Director
- Venkata Radhakrishna Racharla - Company Secretary
- Sarath Chandra Reddy Penaka - Director
The CIN (Corporate Identification Number) of Auronext Pharma Private Limited is U74999TG2009PTC109591. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The primary industry of Auronext Pharma Private Limited is pharma. The company specifically operates in drug formulation and development.